Leukocyte count and fibrinogen are associated with carotid and femoral intima-media thickness in a risk population for diabetes

Cardiovascular Research

Volumn 56, Issue 2, 2002, Pages 277-283

  Temelkova Kurktschiev, Theodora ^a   Koehler, Carsta ^a   Henkel, Elena ^a   Hanefeld, Markolf ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Atherosclerosis; Diabetes; Infection inflammation; Leukocytes

Indexed keywords

ALBUMIN; FIBRINOGEN; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; PLASMINOGEN ACTIVATOR INHIBITOR; PROINSULIN; TISSUE PLASMINOGEN ACTIVATOR; TRIACYLGLYCEROL; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTERY WALL; ARTICLE; ATHEROSCLEROSIS; B SCAN; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR RISK; CAROTID ARTERY; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; FEMORAL ARTERY; GLUCOSE BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INFLAMMATION; INSULIN BLOOD LEVEL; INTIMA; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL ACTIVITY; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; STATISTICAL ANALYSIS; TRIACYLGLYCEROL BLOOD LEVEL; TUNICA MEDIA;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTERIOSCLEROSIS; CAROTID ARTERY, COMMON; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; FEMORAL ARTERY; FIBRINOGEN; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK FACTORS; TUNICA INTIMA; TUNICA MEDIA;

EID: 0036838542     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(02)00547-3     Document Type: Article

References (35)

1. Fuster N., Badimon L., Badimon J.J., Chesebro J.H. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med. 326:1992;242-250.
2. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 362:1993;801-809.
3. Stamler J., Vaccaro O., Neaton J., Wentworth D., For the Multiple Risk Factor Intervention Trial Research Group . Diabetes, other risk factors, and 12-year cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care. 16:1993;434-449.
4. Linnanmaki E., Leinonen M., Mattila K., et al. Presence of Chlamydia pneumoniae-specific antibodies in circulating immune complexes in coronary heart disease. Circulation. 87:1993;1130-1134.
5. Thom D.H., Grayston T., Siscovick D.S., et al. Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. J Am Med Assoc. 268:1992;68-72.
6. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 340:1999;115-126.
7. Munro J.M., Cotran R.S. Biology of disease: the pathogenesis of atherosclerosis: atherogenesis and inflammation. Lab Invest. 58:1988;249-261.
8. Boyle J.J. Association of coronary plaque rupture and atherosclerotic inflammation. J Pathol. 181:1997;93-99.
9. Yarnell J.W., Baker I.A., Sweetnam P.M., et al. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease: the Caerphilly and Speedwell Collaborative Heart Disease Studies. Circulation. 83:1991;836-844.
10. Thompson S.G., Kienast J., Pyke S.D.M., Haverkate F., van de Loo J.C.W. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med. 332:1995;635-641.
11. Kannel W.B., Anderson K., Wilson P.W.F. White blood cell count and cardiovascular disease: insights from the Framingham Study. J Am Med Assoc. 257:1992;1253-1256.
12. Haverkate F., Thompson S.G., Pyke S.D.M., Gallimore J.R., Pepys M.B. Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet. 349:1997;462-466.
13. Tracy R.P., Lemaitre R.N., Psaty B., et al. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly: results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler Thromb Vasc Biol. 17:1997;1121-1127.
14. Ridker P.M., Cushman M., Stampfer M.J., Tracy R.P., Hennekens C.H. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 336:1997;973-979.
15. Noll G. Pathogenesis of atherosclerosis: a possible relation to infection. Atherosclerosis. 140:1998;S3-9.
16. Packard C.J., O'Reilly D.S.J., Caslake M.J., et al. For the West of Scotland Coronary Prevention Study Group . Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. N Engl J Med. 343:2000;1148-1155.
17. Kiechl S., Egger G., Mayr M., et al. Chronic infections and the risk of carotid atherosclerosis. Prospective results from a large population study. Circulation. 103:2001;1064-1071.
18. Zoccali C., Benedetto F.A., Mallamaci F., et al. Inflammation is associated with carotid atherosclerosis in dialysis patients. Creed Investigators. Cardiovascular Risk Extended Evaluation in Dialysis Patients. J Hypertens. 18:2000;1207-1213.
19. Pignoli P., Tremoli E., Poli A., Oreste P., Paoletti R. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation. 74:1986;1399-1406.
20. O'Leary D.H., Polak J.F., Kronmal R.A., et al. For the Cardiovascular Health Study Collaborative Research Group . Carotid artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med. 340:1999;14-22.
21. Temelkova-Kurktschiev T.S., Koehler C., Leonhardt W., et al. Increased intimal-medial thickness in newly detected type 2 diabetes. Diabetes Care. 22:1999;333-338.
22. Temelkova-Kurktschiev T., Henkel E., Schaper F., et al. Prevalence and atherosclerosis risk in different types of non-diabetic hyperglycemia. Is mild hyperglycemia an underestimated evil? Exp Clin Endocrinol Diabetes. 108:2000;93-99.
23. Puckup J.C., Mattock M.B., Chusney G.D., et al. NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia. 40:1997;1286-1292.
24. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). J Am Med Assoc. 285:2001;2486-2497.
25. Temelkova-Kurktschiev T., Koehler C., Schaper F., et al. Relationship between fasting plasma glucose, atherosclerosis risk factors and carotid intima media thickness in nondiabetic individuals. Diabetologia. 41:1998;706-712.
26. Declaration of Helsinki. Cardiovasc Res. 35:1997;2-3.
27. Wendelberg I., Gustavsson T., Suurküla M., Berglund G., Wikstrand J. Ultrasound measurement of wall thickness in the carotid artery. Fundamental principles and description of a computerized analysing system. Clin Physiol. 11:1991;565-577.
28. Haffner S.M., Haffner S.M., Lehto S., et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 339:1998;229-234.
29. Festa A., D'Agostino R., Howard G., et al. Chronic subclinical inflammation as part of the insulin resistance syndrome. The Insulin Resistance Atherosclerosis Study (IRAS). Circulation. 102:2000;42-47.
30. Fröhlich M., Imhof A., Berg G., et al. Association between C-reactive protein and features of the metabolic syndrome. Diabetes Care. 23:2000;1835-1839.
31. Targher G., Seidell J.C., Tonoli M., et al. The white blood cell count: its relationship to plasma insulin and other cardiovascular risk factors in healthy male individuals. J Intern Med. 239:1996;435-441.
32. Yudkin J.S., Stehouwer C.D., Emeis J.J., Coppack S.W. C-reactive protein in healthy subjects: association with obesity, insulin resistance, and endothelial dysfunction: a potent role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol. 19:1999;972-978.
33. Hotamisligil G.S., Spiegelman B.M. Tumor necrosis factor alpha: a key component of the obesity-diabetes link. Diabetes. 43:1994;1271-1278.
34. Pickup J.C., Mattock M.B., Chusney G.D., et al. NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia. 40:1997;1286-1292.
35. Tracy R.P. Inflammation in cardiovascular disease: cart, horse, or both? Circulation. 97:1998;2000-2002.